The Guangzhou Municipal Medical Security Bureau issued a number of measures to support the development of innovative medicines by health insurance in Guangzhou. Among them, it is mentioned that with the exception of drugs negotiated by the country and pharmaceutical devices purchased in centralized quantities, other pharmaceutical devices are independently negotiated by enterprises and medical institutions. The Guangzhou GPO platform normalizes price linkage for innovative pharmaceutical devices in the bargaining category. Urge designated medical institutions to hold pharmaceutical meetings and promptly include nationally negotiated pharmaceuticals and innovative pharmaceutical devices in the scope of procurement by medical institutions, and include relevant information in medical insurance assessments and evaluations.
广州：督促定点医疗机构及时将国谈药品、创新药械纳入医疗机构采购范围
Guangzhou: Urge designated medical institutions to promptly include state-negotiated pharmaceuticals and innovative pharmaceutical devices in the scope of procurement of medical institutions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.